Compare ADMA Biologics Inc (ADMA) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Old Dominion Freight Line Inc — how do they compare? ADMA Biologics Inc trades at $9.28 (market cap $2.13B), while Old Dominion Freight Line Inc trades at $217.16 (market cap $44.82B). The key difference: Old Dominion Freight Line Inc is far larger — about 21× ADMA Biologics Inc's market cap, and Old Dominion Freight Line Inc pays a 0.54% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | ODFL | |
|---|---|---|
Market Cap | $2.13B | $44.82B |
Sector | Health | Industrials |
52-Week High | $20.38 | $248.73 |
52-Week Low | $7.60 | $126.29 |
Enterprise Value | $2.20B | $44.58B |
Dividend Yield | — | 0.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
ODFL trades at $215.51, down 0.98% today, with technical indicators showing a bearish trend near support at $214. The company maintains strong fundamentals with a Q1 2026 EPS beat of $1.14 versus $1.05 expected, though revenue declined to $5.5B in 2025. Valuation remains elevated with a P/E of 45.18 and P/S of 8.35, while profitability metrics like ROE of 23.33% and net margin of 18.46% highlight operational efficiency.
The outlook is mixed: analyst consensus targets $230.69 with 33% buy ratings, but near-term risks include Amazon's LTL expansion (Barron's, June 10, 2026) and high valuation concerns. Cash flow stability and debt-free balance sheet support long-term potential, though investors face headwinds from freight market volatility and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
